Skip to main content

and
  1. Article

    Open Access

    Comparison of the efficacy of taxanes with carboplatin and anthracyclines with taxanes in neoadjuvant chemotherapy for stage II–III triple negative breast cancer: a retrospective analysis

    The neoadjuvant chemotherapy (NACT) regimen for triple negative breast cancer (TNBC) primarily consists of anthracyclines and taxanes, and the addition of platinum-based drugs can further enhance the efficacy....

    Huibo Wang, Nana Zhang, Qi Sun, Ziqi Zhao in Journal of Cancer Research and Clinical On… (2024)

  2. No Access

    Article

    The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients

    Systemic immune-inflammatory markers have a certain predictive role in pathological complete response (pCR) after neoadjuvant treatment (NAT) in breast cancer. However, there is a lack of research exploring th...

    Huibo Wang, Zhenfeng Huang, Bingqi Xu, **xing Zhang in Clinical and Translational Oncology (2024)

  3. Article

    Open Access

    Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription

    Epidemiological studies have confirmed that abnormal circadian rhythms are associated with tumorigenesis in breast cancer. However, few studies have investigated the pathological roles of rhythm genes in breas...

    Weiwei Yang, **g Li, Minghui Zhang in Journal of Experimental & Clinical Cancer … (2022)

  4. Article

    Open Access

    Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0–1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database

    The benefit of adjuvant chemotherapy in invasive lobular carcinoma (ILC) is still unclear. The objective of the current study was to elucidate the effectiveness of adjuvant chemotherapy in hormone receptor (HR...

    Guangfu Hu, Guangxia Hu, Chengjiao Zhang, **aoyan Lin, Ming Shan, Yanmin Yu in BMC Cancer (2020)

  5. No Access

    Article

    Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese

    The development of breast cancer is a multistep process associated with complex changes in host gene expression patterns including inactivation of tumor suppressor genes and activation of oncogenes. Critically...

    Da Pang, Yashuang Zhao, Weinan Xue, Ming Shan, Yanbo Chen, Youxue Zhang in Medical Oncology (2012)

  6. No Access

    Article

    Susceptibility to AcMNPV and expression of recombinant proteins by a novel cell clone derived from a Trichoplusia ni QAU-BTI-Tn9-4s cell line

    It is well known that Tn5B1-4 (commercially known as the High Five) cell line is highly susceptible to baculovirus and provides superior production of recombinant proteins when compared to other insect cell li...

    Ming Shan, Shi-ying Zhang, Lei Jiang, Ming Ma, Guo-xun Li in Virologica Sinica (2011)